Circulating endothelial cells in pulmonary hypertension

Summary

The pulmonary endothelium plays a significant role in the pathobiology of Primary Pulmonary Hypertension. A number of diseases, related by a history of vascular injury, are associated with increased numbers of circulating endothelial cells (CECs). We hypothesized that patients with pulmonary hypertension would also have an increased number of circulating endothelial cells due to the high pressures and increased shear stress present within the pulmonary vasculature. We isolated the CECs from 14 patients with pulmonary hypertension, (5 primary and 11 secondary) and compared them to the cells from 12 normal controls. There was a significant increase in the number of CECs in peripheral blood in patients with both PPH and secondary pulmonary hypertension (SPH) when compared to normal volunteers (33.1 +/- 1.9 {PPH} and 27.2 +/- 6.9 {SPH} vs. 3.5 +/- 1.3 {controls}, p < 0.001). The number of circulating endothelial cells in the patient’s peripheral blood correlated significantly with the systolic, diastolic and mean pulmonary artery pressures of the individual. Approximately 50% of the CECs from patients with pulmonary hypertension expressed CD36, a marker of microvascular origin and 25% expressed E-selectin, a marker of endothelial cell activation. Although the origin of the CECs in patients with PH requires further investigation, one possible source is the pulmonary vasculature, and in patients with plexogenic pulmonary hypertension, the plexiform lesions. CECs may provide a non-invasive mean of accessing cells important to the pathobiology of severe pulmonary hypertension.

Keywords

Circulating endothelial cells - plexiform lesion - angiogenesis - primary pulmonary hypertension

• References

• 1 Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336 (02) 111-7.
• 2 Tuder RM, Lee SD, Cool CC. Histopathology of pulmonary hypertension. Chest 1998; 114 1 Suppl 1S-6S.
• 3 Voelkel NF, Tuder RM. Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 1999; 14 (06) 1246-50.
• 4 Cool CD, Stewart JS, Werahera P. et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155 (02) 411-9.
• 5 Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?. J Anat 2002; 201 (04) 335-48.
• 6 Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Endothelium Clin Chest Med 2001; 22 (03) 405-18.
• 7 Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension [In Process Citation]. Circ Res 2001; 88 (01) E2-E11.
• 8 Mutunga M, Fulton B, Bullock R. et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001; 163 (01) 195-200.
• 9 Woywodt A, Streiber F, de Groot K, Regels-berger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small- vessel vasculitis. Lancet 2003; 361 9353 206-10.
• 10 Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia [see comments]. N Engl J Med 1997; 337 (22) 1584-90.
• 11 Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93 (09) 2951-8.
• 12 George F, Brouqui P, Boffa MC. et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever [see comments]. Blood 1993; 82 (07) 2109-16.
• 13 Lefevre P, George F, Durand JM, Sampol J. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura [letter]. Thromb Haemost 1993; 69 5: 522
• 14 Grefte A, van der GM, van Son W, The TH. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993; 167 (02) 270-7.
• 15 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52 (11) 2745-56.
• 16 Solovey AN, Gui L, Chang L, Enenstein J, Browne PV, Hebbel RP. Identification and functional assessment of endothelial P1H12. J Lab Clin Med 2001; 138 (05) 322-31.
• 17 Cool CD, Stewart JS, Werahera P. et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155 (02) 411-9.
• 18 Voelkel NF, Tuder RM. Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 1999; 14 (06) 1246-50.
• 19 Eddahibi S, Humbert M, Sediame S. et al. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med 2000; 162 4 Pt 1 1493-9.
• 20 Gill M, Dias S, Hattori K. et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88 (02) 167-74.